Project Details
Description
A PHASE 1, FIRST IN HUMAN, DOSE-ESCALATION STUDY OF TORL-1-23 IN PARTICIPANTS WITH ADVANCED CANCER
| Status | Active |
|---|---|
| Effective start/end date | 4/1/22 → 1/1/26 |
Funding
- TORL BIOTHERAPEUTICS, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.